Industry:Biotech & Pharma
Ikaria Inc (IKAR:US)
Ikaria, Inc. operates as a biotherapeutics company. The Company offers acute care therapies for critically ill patients, as well as utilizes science to develop biotherapeutic solutions for the critical care market. Ikaria provides inhalation treatments for patients with hypoxic respiratory failure associated with clinical evidence of pulmonary hypertension in the United States.